VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

被引：305

作者：

Carmeliet, P ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium

来源：

NATURE MEDICINE | 2000年 / 6卷 / 10期

关键词：

D O I：

10.1038/80430

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 [生物化学与分子生物学]; 081704 [应用化学];

摘要：

The finding that unregulated, continuous delivery of vascular endothelial growth factor to the myocardium causes the formation of hemangiomas and death in mice indicates that more research is required on this potent molecule before clinical trials can proceed.

引用

页码：1102 / 1103

页数：2

共 14 条

[1]

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 [J].

Carmeliet, P ;

Ng, YS ;

Nuyens, D ;

Theilmeier, G ;

Brusselmans, K ;

Cornelissen, I ;

Ehler, E ;

Kakkar, VV ;

Stalmans, I ;

Mattot, V ;

Perriard, JC ;

Dewerchin, M ;

Flameng, W ;

Nagy, A ;

Lupu, F ;

Moons, L ;

Collen, D ;

D'Amore, PA ;

Shima, DT .

NATURE MEDICINE, 1999, 5 (05) :495-502

[2]

Mechanisms of angiogenesis and arteriogenesis [J].

Carmeliet, P .

NATURE MEDICINE, 2000, 6 (04) :389-395

[3]

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].

Carmeliet, P ;

Ferreira, V ;

Breier, G ;

Pollefeyt, S ;

Kieckens, L ;

Gertsenstein, M ;

Fahrig, M ;

Vandenhoeck, A ;

Harpal, K ;

Eberhardt, C ;

Declercq, C ;

Pawling, J ;

Moons, L ;

Collen, D ;

Risau, W ;

Nagy, A .

NATURE, 1996, 380 (6573) :435-439

[4]

Clinical applications of angiogenic growth factors and their inhibitors [J].

Ferrara, N ;

Alitalo, K .

NATURE MEDICINE, 1999, 5 (12) :1359-1364

[5]

Gerber HP, 1999, DEVELOPMENT, V126, P1149

[6]

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure [J].

Heymans, S ;

Luttun, A ;

Nuyens, D ;

Theilmeier, G ;

Creemers, E ;

Moons, L ;

Dyspersin, GD ;

Cleutjens, JPM ;

Shipley, M ;

Angellilo, A ;

Levi, M ;

Nübe, O ;

Baker, A ;

Keshet, E ;

Lupu, F ;

Herbert, JM ;

Smits, JFM ;

Shapiro, SD ;

Baes, M ;

Borgers, M ;

Collen, D ;

Daemen, MJAP ;

Carmeliet, P .

NATURE MEDICINE, 1999, 5 (10) :1135-1142

[7]

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF(165) in patient with ischaemic limb [J].

Isner, JM ;

Pieczek, A ;

Schainfeld, R ;

Blair, R ;

Haley, L ;

Asahara, T ;

Rosenfield, K ;

Razvi, S ;

Walsh, E ;

Symes, JF .

LANCET, 1996, 348 (9024) :370-374

[8]

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121 [J].

Lee, LY ;

Patel, SR ;

Hackett, NR ;

Mack, CA ;

Polce, DR ;

El-Sawy, T ;

Hachamovitch, R ;

Zanzonico, P ;

Sanborn, TA ;

Parikh, M ;

Isom, OW ;

Crystal, RG ;

Rosengart, TK .

ANNALS OF THORACIC SURGERY, 2000, 69 (01) :14-23

[9]

Lee RJ, 2000, CIRCULATION, V102, P898

[10]

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice [J].

Moulton, KS ;

Heller, E ;

Konerding, MA ;

Flynn, E ;

Palinski, W ;

Folkman, J .

CIRCULATION, 1999, 99 (13) :1726-1732

← 1 2 →